Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study †

SIMPLE SUMMARY: In this manuscript, we present a statistical model for reliable and early prediction of treatment failure in patients with diffuse large B-cell lymphoma. The model combines measurable parameters—namely, the metabolic tumor volume and the metabolic heterogeneity, from baseline PET/CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Genta, Sofia, Ghilardi, Guido, Cascione, Luciano, Juskevicius, Darius, Tzankov, Alexandar, Schär, Sämi, Milan, Lisa, Pirosa, Maria Cristina, Esposito, Fabiana, Ruberto, Teresa, Giovanella, Luca, Hayoz, Stefanie, Mamot, Christoph, Dirnhofer, Stefan, Zucca, Emanuele, Ceriani, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870624/
https://www.ncbi.nlm.nih.gov/pubmed/35205765
http://dx.doi.org/10.3390/cancers14041018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870624/
https://www.ncbi.nlm.nih.gov/pubmed/35205765
http://dx.doi.org/10.3390/cancers14041018

Ejemplares similares